The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies
Open accessAbstract
BACKGROUND: Controversy persists about optimal mammography screening strategies. OBJECTIVE: To evaluate screening outcomes, taking into account advances in mammography and treatment of breast cancer. DESIGN: Collaboration of 6 simulation models using national data on incidence, digital mammography performance, treatment effects, and other-cause mortality. SETTING: United States. PATIENTS: Average-risk U.S. female population and subgroups with varying risk, breast density, or comorbidity. INTERVENTION: Eight strategies differing by age at which screening starts (40, 45, or 50 years) and screening interval (annual, biennial, and hybrid [annual for women in their 40s and biennial thereafter]). All strategies assumed 100% adherence and stopped at age 74 years. MEASUREMENTS: Benefits (breast cancer-specific mortality reduction, breast cancer deaths averted, life-years, and quality-adjusted life-years); number of mammograms used; harms (false-positive results, benign biopsies, and overdiagnosis); and ratios of harms (or use) and benefits (efficiency) per 1000 screens. RESULTS: Biennial strategies were consistently the most efficient for average-risk women. Biennial screening from age 50 to 74 years avoided a median of 7 breast cancer deaths versus no screening; annual screening from age 40 to 74 years avoided an additional 3 deaths, but yielded 1988 more false-positive results and 11 more overdiagnoses per 1000 women screened. Annual screening from age 50 to 74 years was inefficient (similar benefits, but more harms than other strategies). For groups with a 2- to 4-fold increased risk, annual screening from age 40 years had similar harms and benefits as screening average-risk women biennially from 50 to 74 years. For groups with moderate or severe comorbidity, screening could stop at age 66 to 68 years. LIMITATION: Other imaging technologies, polygenic risk, and nonadherence were not considered. CONCLUSION: Biennial screening for breast cancer is efficient for average-risk populations. Decisions about starting ages and intervals will depend on population characteristics and the decision makers' weight given to the harms and benefits of screening. PRIMARY FUNDING SOURCE: National Institutes of Health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammographic Density and the Risk and Detection of Breast Cancer
Boyd, N. F., Guo, H., Martin, L. J., Sun, L., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062790 · Cited by 2,478
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Self-citationScreening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
Pisano, E. D., Gatsonis, C., Hendrick, E., Yaffe, M., Baum, J. K., Acharyya, S., Conant, E. F., Fajardo, L. L., Bassett, L., D'Orsi, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052911 · Cited by 1,940
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Walter, L. C., & Covinsky, K. E. (2001) · JAMA · doi:10.1001/jama.285.21.2750 · Cited by 1,003
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., & Straif, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 962
Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography
Friedewald, S. M., Rafferty, E. A., Rose, S. L., Durand, M. A., Plecha, D. M., Greenberg, J. S., Hayes, M. K., Copit, D. S., Carlson, K. L., Cink, T. M., et al. (2014) · JAMA · doi:10.1001/jama.2014.6095 · Cited by 851
Hoffmann, T. C., & Del Mar, C. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6016 · Cited by 707
Miller, A. B., Wall, C., Baines, C. J., Sun, P., To, T., & Narod, S. A. (2014) · BMJ · doi:10.1136/bmj.g366 · Cited by 702
Effect of Age, Breast Density, and Family History on the Sensitivity of First Screening Mammography
Kerlikowske, K. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540010035027 · Cited by 624
Self-citationMandelblatt, J. S., Cronin, K. A., Bailey, S., Berry, D. A., de Koning, H. J., Draisma, G., Huang, H., Lee, S. J., Munsell, M., Plevritis, S. K., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00010 · Cited by 605
Self-citationPrediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Mavaddat, N., Pharoah, P. D. P., Michailidou, K., Tyrer, J., Brook, M. N., Bolla, M. K., Wang, Q., Dennis, J., Dunning, A. M., Shah, M., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv036 · Cited by 550
Self-citationMoss, S. M., Cuckle, H., Evans, A., Johns, L., Waller, M., & Bobrow, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69834-6 · Cited by 503
Broeders, M., Moss, S., Nyström, L., Njor, S., Jonsson, H., Paap, E., Massat, N., Duffy, S., Lynge, E., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012078 · Cited by 489
Prospective Breast Cancer Risk Prediction Model for Women Undergoing Screening Mammography
Barlow, W. E., White, E., Ballard-Barbash, R., Vacek, P. M., Titus-Ernstoff, L., Carney, P. A., Tice, J. A., Buist, D. S. M., Geller, B. M., Rosenberg, R., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj331 · Cited by 463
Self-citationTHE SWEDISH TWO-COUNTY TRIAL TWENTY YEARS LATER
Tabár, L., Vitak, B., Chen, H.-H., Duffy, S. W., Yen, M.-F., Chiang, C.-F., Krusemo, U. B., Tot, T., & Smith, R. A. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70191-3 · Cited by 460
Risk Factors for Breast Cancer for Women Aged 40 to 49 Years: A Systematic Review and Meta-analysis
Nelson, H. D., Zakher, B., Cantor, A., Fu, R., Griffin, J., O'Meara, E. S., Buist, D. S. M., Kerlikowske, K., van Ravesteyn, N. T., Trentham-Dietz, A., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-9-201205010-00006 · Cited by 425
Self-citationGenome-wide association studies identify four ER negative–specific breast cancer risk loci
The Gene ENvironmental Interaction and breast CAncer (GENICA) Network, Garcia-Closas, M., kConFab Investigators, (FBCS), F. B. C. S., Australian Breast Cancer Tissue Bank (ABCTB) Investigators, Couch, F. J., Lindstrom, S., Michailidou, K., Schmidt, M. K., Brook, M. N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2561 · Cited by 406
Prevalence of Mammographically Dense Breasts in the United States
Sprague, B. L., Gangnon, R. E., Burt, V., Trentham-Dietz, A., Hampton, J. M., Wellman, R. D., Kerlikowske, K., & Miglioretti, D. L. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju255 · Cited by 400
Self-citationHanmer, J., Lawrence, W. F., Anderson, J. P., Kaplan, R. M., & Fryback, D. G. (2006) · Medical Decision Making · doi:10.1177/0272989x06290497 · Cited by 395
Performance Benchmarks for Screening Mammography
Rosenberg, R. D., Yankaskas, B. C., Abraham, L. A., Sickles, E. A., Lehman, C. D., Geller, B. M., Carney, P. A., Kerlikowske, K., Buist, D. S. M., Weaver, D. L., et al. (2006) · Radiology · doi:10.1148/radiol.2411051504 · Cited by 336
Self-citationSchousboe, J. T., Kerlikowske, K., Loh, A., & Cummings, S. R. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-1-201107050-00003 · Cited by 317
Self-citationIdentifying Women With Dense Breasts at High Risk for Interval Cancer: A Cohort Study
Kerlikowske, K., Zhu, W., Tosteson, A. N. A., Sprague, B. L., Tice, J. A., Lehman, C. D., Miglioretti, D. L., & for the Breast Cancer Surveillance Consortium* (2015) · Annals of Internal Medicine · doi:10.7326/m14-1465 · Cited by 286
Self-citationKerlikowske, K., Hubbard, R. A., Miglioretti, D. L., Geller, B. M., Yankaskas, B. C., Lehman, C. D., Taplin, S. H., Sickles, E. A., & for the Breast Cancer Surveillance Consortium (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00005 · Cited by 268
Self-citationGenetic Susceptibility to Triple-Negative Breast Cancer
Stevens, K. N., Vachon, C. M., & Couch, F. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1699 · Cited by 223
Matamala, N., Vargas, M. T., González-Cámpora, R., Miñambres, R., Arias, J. I., Menéndez, P., Andrés-León, E., Gómez-López, G., Yanowsky, K., Calvete-Candenas, J., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238691 · Cited by 222
Sprague, B. L., Stout, N. K., Schechter, C., van Ravesteyn, N. T., Cevik, M., Alagoz, O., Lee, C. I., van den Broek, J. J., Miglioretti, D. L., Mandelblatt, J. S., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0692 · Cited by 217
Self-citationRetrospective Cost-effectiveness Analysis of Screening Mammography
Stout, N. K., Rosenberg, M. A., Trentham-Dietz, A., Smith, M. A., Robinson, S. M., & Fryback, D. G. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj210 · Cited by 209
Self-citationOutcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy
Kerlikowske, K., Zhu, W., Hubbard, R. A., Geller, B., Dittus, K., Braithwaite, D., Wernli, K. J., Miglioretti, D. L., O’Meara, E. S., & Breast Cancer Surveillance Consortium, F. T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.307 · Cited by 209
Self-citationQuantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
Carter, J. L., Coletti, R. J., & Harris, R. P. (2015) · BMJ · doi:10.1136/bmj.g7773 · Cited by 207
Smith, R. A., Cokkinides, V., & Brawley, O. W. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20143 · Cited by 203
Quantifying the Benefits and Harms of Screening Mammography
Welch, H. G., & Passow, H. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13635 · Cited by 202
Cho, H., Klabunde, C. N., Yabroff, K. R., Wang, Z., Meekins, A., Lansdorp-Vogelaar, I., & Mariotto, A. B. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-10-201311190-00005 · Cited by 164
Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model
Fryback, D. G., Stout, N. K., Rosenberg, M. A., Trentham-Dietz, A., Kuruchittham, V., & Remington, P. L. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj007 · Cited by 163
Self-citationBenign Breast Disease, Mammographic Breast Density, and the Risk of Breast Cancer
Tice, J. A., O’Meara, E. S., Weaver, D. L., Vachon, C. M., Ballard-Barbash, R. R., & Kerlikowske, K. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt124 · Cited by 154
Self-citationLansdorp‐Vogelaar, I., Gulati, R., Mariotto, A. B., Schechter, C. B., de Carvalho, T. M., Knudsen, A. B., van Ravesteyn, N. T., Heijnsdijk, E. A. M., Pabiniak, C. J., van Ballegooijen, M., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2867 · Cited by 149
Self-citationEffects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality
Muñoz, D. F., Near, A. M., van Ravesteyn, N. T., Lee, S. J., Schechter, C. B., Alagöz, O., Berry, D. A., Burnside, E. S., Chang, Y.-J., Chisholm, G. B., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju289 · Cited by 146
Self-citationCost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer
Vilaprinyó, E., Forné, C., Carles-Lavila, M., Sala, M., Pla, R., Castells, X., Domingo, L., Rué, M., & the Interval Cancer (INCA) Study Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0086858 · Cited by 142
Etzioni, R., Gulati, R., Mallinger, L., & Mandelblatt, J. S. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00008 · Cited by 139
Self-citationSchonberg, M. A., Davis, R. B., McCarthy, E. P., & Marcantonio, E. R. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03523.x · Cited by 120
Chapter 4: Changing Patterns in Breast Cancer Incidence Trends
Holford, T. R., Cronin, K. A., Mariotto, A. B., & Feuer, E. J. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj016 · Cited by 112
Self-citationAssessing the effectiveness of health interventions for cost-effectiveness analysis
Mandelblatt, J. S., Fryback, D. G., Weinstein, M. C., Russell, L. B., & Gold, M. R. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.07107.x · Cited by 104
Self-citationBerry, D. A., Inoue, L. Y. T., Shen, Y., et al. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj006 · Cited by 101
Self-citationEuropean Breast Cancer Service Screening Outcomes: A First Balance Sheet of the Benefits and Harms
Paci, E., Broeders, M. J. M., Hofvind, S. S. H., Puliti, D., Duffy, S. W., & the EUROSCREEN Working Group (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0320 · Cited by 96
Obesity, Mammography Use and Accuracy, and Advanced Breast Cancer Risk
Kerlikowske, K. M., Walker, R. L., Miglioretti, D. L., Desai, A. S., Ballard-Barbash, R. R., & Buist, D. S. M. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn388 · Cited by 96
Self-citationBraithwaite, D., Zhu, W., Hubbard, R. A., O’Meara, E. S., Miglioretti, D. L., Geller, B. M., Dittus, K. L., Moore, D. H., Wernli, K. J., Mandelblatt, J. S., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs645 · Cited by 90
Self-citationChapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer
Tan, S., van Oortmarssen, G. J., de Koning, H. J., Boer, R., & Habbema, J. D. F. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj009 · Cited by 85
Fenton, J. J., Xing, G., Elmore, J. G., Bang, H., Chen, S. L., Lindfors, K. K., & Baldwin, L. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-8-201304160-00002 · Cited by 73
Mandelblatt, J. S., Schechter, C. B., Lawrence, W., Yi, B., & Cullen, J. C. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj008 · Cited by 70
Self-citationPublic Opinions about Overdiagnosis: A National Community Survey
Moynihan, R. N., Nickel, B., Hersch, J. K., Beller, E., Doust, J. A., Compton, S., Barratt, A. L., Bero, L. A., & McCaffery, K. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125165 · Cited by 69
Mariotto, A. B., Wang, Z., Klabunde, C. N., Cho, H., Das, B., & Feuer, E. J. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.07.002 · Cited by 69
Self-citationStone, J., Thompson, D. J., dos‐Santos‐Silva, I., Scott, C. G., Tamimi, R. M., Lindström, S., Kraft, P., Hazra, A., Li, J., Eriksson, L., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2012 · Cited by 66
Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis
van Ravesteyn, N. T., Stout, N. K., Schechter, C. B., Heijnsdijk, E. A. M., Alagöz, O., Trentham‐Dietz, A., Mandelblatt, J. S., & de Koning, H. J. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv103 · Cited by 62
Self-citationTrentham‐Dietz, A., Sprague, B. L., Hampton, J. M., Miglioretti, D. L., Nelson, H. D., Titus, L. J., Egan, K. M., Remington, P., & Newcomb, P. A. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2905-y · Cited by 50
Self-citationChapter 12: A Stochastic Simulation Model of U.S. Breast Cancer Mortality Trends From 1975 to 2000
Plevritis, S. K., Sigal, B. M., Salzman, P., Rosenberg, J., & Glynn, P. W. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj012 · Cited by 50
Self-citationClarke, L. D., Plevritis, S. K., Boer, R., Cronin, K. A., & Feuer, E. J. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj013 · Cited by 48
Self-citationA Reality Check for Overdiagnosis Estimates Associated With Breast Cancer Screening
Etzioni, R., Xia, J., Hubbard, R. A., Weiss, N. S., & Gulati, R. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju315 · Cited by 47
Chang, Y.-J., Schechter, C. B., van Ravesteyn, N. T., Near, A. M., Heijnsdijk, E. A. M., Adams-Campbell, L. L., Levy, D. T., de Koning, H. J., & Mandelblatt, J. S. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2274-3 · Cited by 25
Self-citationSmith, R. A. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0946 · Cited by 22
Impact of Mammography Screening Interval on Breast Cancer Diagnosis by Menopausal Status and BMI
Dittus, K. L., Geller, B. M., Weaver, D. L., Kerlikowske, K. M., Zhu, W., Hubbard, R. A., Braithwaite, D., O’Meara, E. S., & Miglioretti, D. L. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2507-0 · Cited by 19
Self-citation
Cited by
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue
Bakker, M. F., de Lange, S. V., Pijnappel, R. M., Mann, R. M., Peeters, P. H. M., Monninkhof, E. M., Emaus, M. J., Loo, C. E., Bisschops, R. H. C., Lobbes, M. B. I., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903986 · Cited by 702
Self-citationKnudsen, A. B., Zauber, A. G., Rutter, C. M., Naber, S. K., Doria-Rose, V. P., Pabiniak, C., Johanson, C., Fischer, S. E., Lansdorp-Vogelaar, I., & Kuntz, K. M. (2016) · JAMA · doi:10.1001/jama.2016.6828 · Cited by 474
Brozek, J. L., Canelo-Aybar, C., Akl, E. A., Bowen, J. M., Bucher, J., Chiu, W. A., Cronin, M., Djulbegovic, B., Falavigna, M., Guyatt, G. H., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.09.018 · Cited by 331
Metadata
- Authors
- Mandelblatt, J. S., Stout, N. K., Schechter, C. B., van den Broek, J. J., Miglioretti, D. L., Krapcho, M., Trentham-Dietz, A., Munoz, D., Lee, S. J., Berry, D. A., van Ravesteyn, N. T., Alagoz, O., Kerlikowske, K., Tosteson, A. N. A., Near, A. M., Hoeffken, A., Chang, Y., Heijnsdijk, E. A., Chisholm, G., Huang, X., Huang, H., Ergun, M. A., Gangnon, R., Sprague, B. L., Plevritis, S., Feuer, E., de Koning, H. J., & Cronin, K. A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2016-02-16
- Volume
- 164
- Issue
- 4
- Pages
- 215-225
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2282197435
- Cited by
- 281
- References
- 64
- FWCI
- 16.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.